Health
US to widen inquiry into AstraZeneca COVID vaccine destined for Australia – Sydney Morning Herald
The US regulator has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study, a development closely watched by local regulators…
AstraZeneca has confirmed it is still awaiting the green light from US regulators to resume its US trials. The pharma giant’s Australian office wouldn’t comment further on how any delays would affect the timeline for when Australians receive the vaccine if successful.
Meanwhile, there was better news for the vaccine in Europe overnight, with reports the European Medicines Agency is expected to announce a “rolling review” of the Oxford/AstraZeneca candidate this week.
This would mean the Europe…
-
Noosa News14 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Business16 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News16 hours agoDangerous driving charges, Maroochydore – Sunshine Coast
-
General24 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter